Gapping down
In reaction to earnings/guidance:
- VAPO -22.6% (withdraws FY22 rev guidance due to slowdown in COVID hospitalizations; guides Q1 revs below consensus), IRNT -10.6%, SOFI -4.9% (lowers FY22 rev guidance below consensus), CAG -4.6%
Other news:
- APTX -59.6% (reports results from phase 2b study of NYX-2925)
- CCCS -10.2% (commences 20 mln share public offering by selling shareholders)
- VAXX -3.4% (to receive CEPI funding for Phase 3 UB-612 heterologous booster trial)
- SELB -3.1% (prices offering of 27428572 shares of its common stock and accompanying warrants to purchase up to 20571429 shares of common stock at a combined offering price of $1.41 per share and accompanying warrant )
- AVB -2.4% (prices offering of 2 mln shares of common stock for gross proceeds of $497.2 mln)
Analyst comments:
- W -3.4% (downgraded to Underweight from Equal Weight at Wells Fargo)
- DAN -1.9% (downgraded to Equal Weight from Overweight at Barclays)
- HILI -1.7% (downgraded to Underweight from Neutral at Piper Sandler)
- F -1.2% (downgraded to Equal Weight from Overweight at Barclays)